Drug treatment for hypertension
271 results
30 - 129
Comprehensive treatment and follow-up of type 2 diabetes 
Pharmacotherapy for mild hypertension- Hypertension: investigations, treatment initiation and non-pharmacological treatment
- First‐line combination therapy versus first‐line monotherapy for primary hypertension
- Hypertension in elderly patients
- Phosphodiesterase 5 inhibitors for pulmonary hypertension: Cochrane systematic review
- Pharmacotherapy for hypertension in adults 60 years or older
- Pharmacotherapy for hypertension in the elderly
- Blood pressure lowering efficacy of diuretics as second‐line therapy for primary hypertension
- Use of medication during pregnancy
- First‐line drugs for hypertension
- Prevention and treatment of postpartum hypertension
- Pharmacotherapy for hypertension in adults aged 18 to 59 years
- Spironolactone for hypertension
- Evening versus morning dosing regimen drug therapy for hypertension
- Prostacyclin for pulmonary hypertension in adults
- Blood pressure lowering efficacy of beta‐blockers as second‐line therapy for primary hypertension
- Antihypertensive drug therapy for mild to moderate hypertension during pregnancy
- Hydralazine for essential hypertension
- Blood pressure‐lowering efficacy of reserpine for primary hypertension
- Diabetic kidney disease (diabetic nephropathy)
- Interventions to improve control of blood pressure in hypertension
- Primary hyperaldosteronism (PHA)
- Metabolic syndrome
- First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension: Cochrane systematic review
Some benefit to treating mild hypertension to prevent stroke, CV deaths, and overall mortality- Interventions used to improve control of blood pressure in patients with hypertension: Cochrane systematic review
- Methyldopa for primary hypertension: Cochrane systematic review
- Medical treatment of glaucoma and intraocular hypertension
- Blood pressure lowering efficacy of angiotensin converting enzyme (ACE) inhibitors for primary hypertension: Cochrane systematic review
- Prostacyclin for pulmonary arterial hypertension
- Guanylate cyclase stimulators for pulmonary hypertension
- Blood pressure lowering efficacy of renin inhibitors for primary hypertension
- Calcium channel blockers versus other classes of drugs for hypertension
- Adverse effects of hypertension treatment during pregnancy
- Treatment of hypertension in peripheral arterial disease
- Secondary hypertension
- Medical interventions for primary open angle glaucoma and ocular hypertension
- Blood pressure lowering for prevention of dementia in patients without prior cerebrovascular disease
- Reversal of left ventricular hypertrophy in essential hypertension
- Spironolactone for hypertension: Cochrane systematic review
- Follow-up of type 1 diabetes
- Angiotensin converting enzyme (ACE) inhibitors versus angiotensin receptor blockers for primary hypertension
- Pharmacotherapy for hypertension‐induced left ventricular hypertrophy
- Pharmacotherapy for mild hypertension
- Chronic diseases and pregnancy
- Increased pulmonary blood pressure: pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
- Pharmacological interventions for hypertension in children
- Chronic heart failure
- Treatment of drug addicts
- Oral beta‐blockers for mild to moderate hypertension during pregnancy
- Drugs for treatment of very high blood pressure during pregnancy
- Subcutaneous trepostinil for pulmonary hypertension
- Blood pressure lowering efficacy of angiotensin receptor blockers for primary hypertension: Cochrane systematic review
- Health gains from the treatment of obesity
- Catheter ablation marginally better than usual care for symptomatic atrial fibrillation (CABANA)
- Endothelin receptor antagonists for pulmonary arterial hypertension
- Pharmacological treatment of hypertension in people without prior cerebrovascular disease for the prevention of cognitive impairment and dementia
- 24-hour ambulatory blood pressure readings: more informative for the risks of all-cause and cardiovascular mortality
- First‐line diuretics versus other classes of antihypertensive drugs for hypertension
- Good reasons not to lower the definition of high blood pressure in adults
- Oral antidiabetic drugs and GLP-1 analogues
- Regular long‐term red blood cell transfusions for managing chronic chest complications in sickle cell disease
- Higher blood pressure targets for hypertension in older adults
- Statins for aortic valve stenosis
- Pharmacological interventions for hypertensive emergencies
- Alcohol or drug intoxication
- Long‐term effects of weight‐reducing drugs in people with hypertension
- Magnesium supplementation for the management of primary hypertension in adults
- Primary sclerosing cholangitis
- Effect of antihypertensive drugs on mortality, morbidity and blood pressure in blacks: Cochrane systematic review
- Spironolactone most effective add-on for patients with resistant hypertension (PATHWAY-2)
- Alcoholic liver disease (ALD)
- Antihypertensive pharmacotherapy for prevention of sudden cardiac death in hypertensive individuals
- Blood pressure lowering efficacy of beta‐1 selective beta blockers for primary hypertension